Clinical trial
Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study
NCT05494710 is registered in ClinicalTrials.gov with South Tees Hospitals NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study
- Lead sponsor
- South Tees Hospitals NHS Foundation Trust
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 1, 2020
- Completion date
- December 1, 2022
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.